News

 

At AseBio, we follow the latest news in the biotechnology sector and pass the highlights on to you. You can use the search engine to find news articles we’ve written, contributed by our members or from other stakeholders in the sector. And they are also organised into categories to help you find the topics you’re interested in easily.

Search engine
BCN
BCN HEALTH has published 10 studies in 2022 assessing the incidence and costs of illness of different diseases in Spain
Healthcare · Access to innovation · Corporate
BCN HEALTH has published 10 studies in 2022 assessing the incidence and cost of illness of…
Partners - BCN Health
YSIOS
Ysios Capital strengthens its team with internal promotions and a new Venture Partner
Access to innovation · Corporate
 Jordi Xiol has been promoted to Partner after joining Ysios Capital in 2019 Ysios is also…
Partners - Ysios Capital Partners
itemas
GENESIS Biomed sponsors ITEMAS 2022 Annual Conference Day
Corporate
The “Instituto de Investigación Biomédica de Córdoba” hosts the event, supported by “Instituto de…
Partners - GENESIS Biomed
diversa
DIVERSA Technologies is driven by Innovation
Access to innovation · Corporate
The Galician Innovation Agency has awarded DIVERSA through the InnovaPeme program to implement its…
Partners - DIVERSA Technologies
cellab
Cellab CDMO, Cellab's new activity
Corporate
The Andorran biotech company is working to obtain Good Manufacturing Practices (GMP) during the…
Partners - Cellab
germans
Nimble Diagnostics cierra una ronda de financiación de un millón de euros
Corporate
NIMBLE Diagnostics, ha cerrado con éxito una ronda de financiación donde han conseguido más un…
Partners - Germans Trias i Pujol Research Institute (IGTP)
MIKROBIOMIK
The first orally administered biologic medicine based on intestinal microbiota: fiction or reality?
Healthcare · Access to innovation · Corporate
Mikrobiomik aims to be the first company in the world to commercialize the first biologic medicine…
Partners - Mikrobiomik
oryzon
ORYZON announces First Patient In in NET, a collaborative Phase II basket study with iadademstat in R/R patients with neuroendocrine carcinomas
Healthcare · Access to innovation · Corporate
    Trial will assess the safety and efficacy of iadademstat in pulmonary and…
Partners - Oryzon Genomics
laminar
La biotech española Laminar Pharma alcanza la cifra de 45 pacientes reclutados en el ensayo clínico de fase II/III de LAM561 para el tratamiento del GBM
Healthcare · Corporate
Laminar Pharmaceuticals S.A., se complace en anunciar el reclutamiento de los primeros 45 pacientes…
Partners - Laminar Pharma